Javier Colomina

INCLIVA Health Research Institute

Papers

1

Total Citations

11

H-Index

1

About

Javier Colomina is a clinical microbiologist whose research has been pivotal in refining the diagnostic accuracy of infectious diseases, most notably during the COVID-19 pandemic. His key contributions center on molecular diagnostics, particularly the optimization of RT-PCR testing for SARS-CoV-2. In his highly cited 2020 work, Colomina pioneered the use of human β-glucuronidase gene amplification as an internal control to appraise the reliability of negative RT-PCR results from upper respiratory specimens. This methodological advance directly addressed a critical clinical challenge—the high rate of false negatives in early COVID-19 diagnosis, which could reach up to 30% in symptomatic patients. By providing a robust quality control mechanism, his research helped laboratories distinguish true negatives from inadequate samples, thereby improving patient management and infection control. With 11 citations, this study has become a reference point for diagnostic accuracy studies. Colomina’s work exemplifies how meticulous assay design can enhance the clinical utility of molecular testing, making him a valuable contributor to the field of clinical virology and pandemic preparedness.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Amplification of human β‐glucuronidase gene for appraising the accuracy of negative SARS‐CoV‐2 RT‐PCR results in upper respiratory tract specimens
11 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: INCLIVA Health Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago